pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›LOMUSTINE
drug
save

LOMUSTINE

Marketedupdated 3mo ago
by Carnegie Pharmaceuticals LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 2
  • tagApproval2 co-mentions · 1 sources
  • tagSmall Molecule1 co-mentions · 1 sources

all catalysts(1)

approval · 1
Oct 27, 2025
approval
10mo ago
LOMUSTINE — FDA approval
LOMUSTINE
→

Trials studying LOMUSTINE

  • phase3Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMrecruitingn=560
  • phase3A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastomarecruitingn=2,250
  • phase2A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrenceactive not recruitingn=90
  • phase3Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastomarecruitingn=50
  • phase2A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiformeactive not recruitingn=252
  • phase29-ING-41 in Patients With Advanced Cancersactive not recruitingn=350
  • phase2A Study in Recurrent Glioblastoma (GB)completedn=158
  • phase3VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMterminatedn=2
more trials →

Patent cliff

source: FDA Orange Book

FDA exclusivities (3)

  • May 19, 2026CGTCGT
  • May 19, 2026CGTCGT
  • May 19, 2026CGTCGT

News(0)

no news has mentioned this drug yet

brand
LOMUSTINE
generic
LOMUSTINE
indication
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 43m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?